Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 9/20 | 0.74 |
| ▸ | MMP9 | P14780 | 9/20 | 0.74 |
| ▸ | MMP1 | P03956 | 9/20 | 0.74 |
| ▸ | LMNA | P02545 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | KEAP1 | Q14145 | 3/20 | 0.55 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.52 |
| ▸ | PGR | P06401 | 1/20 | 0.52 |
| ▸ | MMP12 | P39900 | 1/20 | 0.51 |
| ▸ | ADAM17 | P78536 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7325277 | 0.89 | MMP13 (0.81) | MMP13MMP9MMP1LMNAMEN1 | |
| SCHEMBL7323418 | 0.87 | MMP9 (0.61) | MMP13MMP9MMP1LMNAKEAP1 | |
| SCHEMBL7442532 | 0.85 | KEAP1 (0.66) | MMP13MMP9MMP1LMNAMEN1 | |
| SCHEMBL7313498 | 0.85 | MMP9 (1.00) | MMP13MMP9MMP1MMP12ADAM17 | |
| SCHEMBL7323169 | 0.84 | MMP13 (0.74) | MMP13MMP9MMP1LMNAKEAP1 | |
| SCHEMBL7317386 | 0.81 | MMP13 (0.74) | MMP13MMP9MMP1LMNAMEN1 | |
| SCHEMBL7317483 | 0.81 | MMP9 (0.75) | MMP13MMP9MMP1LMNAMEN1 | |
| SCHEMBL7323620 | 0.79 | MMP9 (0.62) | MMP13MMP9MMP1KEAP1NFE2L2 | |
| SCHEMBL7453335 | 0.78 | MMP9 (0.68) | MMP13MMP9MMP1LMNAMEN1 | |
| SCHEMBL7323304 | 0.78 | MMP9 (0.74) | MMP13MMP9MMP1LMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0938471-B1 | THE PREPARATION AND USE OF ORTHO-SULFONAMIDO ARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS | AMERICAN CYANAMID CO (US) | 2001-12-12 | — | — | EP | disclosed |
| CN-1240429-A | Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors | AMERICAN CYANAMID CO (US) | 2000-01-05 | — | — | CN | disclosed |
| EP-0938471-A1 | THE PREPARATION AND USE OF ORTHO-SULFONAMIDO ARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS | American Cyanamid Company (US) | 1999-09-01 | — | — | EP | disclosed |
| US-5929097-A | INHIBIT TUMOR NECROSIS FACTOR-ALPHA CONVERTING ENZYME | AMERICAN CYANAMID COMPANY (US) | 1999-07-27 | — | — | US | disclosed |
| WO-1998016503-A2 | THE PREPARATION AND USE OF ORTHO-SULFONAMIDO ARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1998-04-23 | — | — | WO | disclosed |